ВАН НОРРЕН Класке (NL),ФАБЕР Джойс (NL),ВАН ХЕЛЬФОРТ Адрианус Ламбертус Бертольдус (NL),ХАГЕМАН Роберт Йохан Йосеф (NL)
申请号：
RU2011152873/15
公开号：
RU2011152873A
申请日:
2010.05.27
申请国别(地区):
RU
年份:
2013
代理人:
摘要：
1. The combination of a source of leucine and a source of ω-3 unsaturated fatty acid for use in the therapeutic or prophylactic treatment of hypercalcemia. 2. The combination of the source of leucine and the source of ω-3 unsaturated fatty acid for use in order to reduce the loss of bone mineral density or for use to prevent a decrease in bone mineral density in a subject or for use in order to regulate calcium homeostasis in blood plasma in a subject in vivo, said subject is a subject suffering from cancer. 3. A combination of a source of leucine and a source of ω-3 unsaturated fatty acid for use to improve appetite and / or for use to reduce nausea and / or for use to reduce vomiting. 4. A combination according to any one of claims 1 to 3 for use in order to reduce fatigue. 5. A combination for use according to any one of claims 1 to 3, containing at least a source of one ω-3 polyunsaturated fatty acid, providing an ω-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid. 6. A combination according to any one of claims 1 to 3 for use in the treatment of a subject suffering from cancer, in particular from a cancer selected from the group of lung cancer, breast cancer, kidney cancer, multiple myeloma and head and neck cancer. The combination according to any one of claims 1 to 3 for use in the treatment of excessive release of calcium from bones and / or skeletal muscles； and / or for use in the treatment of excessive accumulation of calcium due to renal failure or hyperparathyroidism. 8. TO1. Комбинация источника лейцина и источника ω-3 ненасыщенной жирной кислоты для применения при терапевтическом или профилактическом лечении гиперкальциемии.2. Комбинация источника лейцина и источника ω-3 ненасыщенной жирной кислоты для применения с целью уменьшения потери минеральной плотности костей или для применения с целью предупреждения уменьшения минеральной плотности костей у суб
